CINECA IRIS Institutional Research Information System

MILLA, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.538
NA - Nord America 5.586
AS - Asia 2.052
SA - Sud America 62
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 16
Totale 16.311
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.486
IT - Italia 5.467
CN - Cina 844
IE - Irlanda 524
FR - Francia 506
SE - Svezia 448
DE - Germania 388
SG - Singapore 341
FI - Finlandia 291
KR - Corea 267
UA - Ucraina 210
GB - Regno Unito 165
PL - Polonia 163
JP - Giappone 155
IN - India 129
VN - Vietnam 99
AT - Austria 82
CA - Canada 68
NL - Olanda 55
ES - Italia 51
CH - Svizzera 49
ID - Indonesia 39
IL - Israele 39
BE - Belgio 36
IR - Iran 34
RO - Romania 28
SN - Senegal 27
MX - Messico 26
TR - Turchia 26
BR - Brasile 23
HK - Hong Kong 18
CO - Colombia 17
RU - Federazione Russa 17
PT - Portogallo 14
TH - Thailandia 14
AU - Australia 13
EU - Europa 13
MY - Malesia 10
DK - Danimarca 9
EG - Egitto 9
SA - Arabia Saudita 8
CZ - Repubblica Ceca 6
EC - Ecuador 6
TW - Taiwan 6
GR - Grecia 5
LT - Lituania 5
PE - Perù 5
PH - Filippine 5
PY - Paraguay 5
UZ - Uzbekistan 4
AR - Argentina 3
AZ - Azerbaigian 3
CL - Cile 3
NZ - Nuova Zelanda 3
SM - San Marino 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AP - ???statistics.table.value.countryCode.AP??? 2
BG - Bulgaria 2
CR - Costa Rica 2
CY - Cipro 2
HR - Croazia 2
IQ - Iraq 2
JO - Giordania 2
LU - Lussemburgo 2
MD - Moldavia 2
PA - Panama 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
GH - Ghana 1
HU - Ungheria 1
MA - Marocco 1
MC - Monaco 1
MT - Malta 1
NO - Norvegia 1
PK - Pakistan 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
Totale 16.311
Salva come PNG Salva come JPEG
Città #
Chandler 656
Beijing 537
Dublin 501
Santa Clara 384
Singapore 255
Houston 250
Fairfield 242
Milan 240
Ann Arbor 238
Rome 235
Torino 201
Villeurbanne 197
Ashburn 188
Medford 166
Dearborn 163
Princeton 161
Jacksonville 149
Columbus 131
Warsaw 126
Wilmington 121
Woodbridge 102
Pisa 94
Nyköping 90
Seattle 90
Cambridge 76
Vienna 76
Munich 71
Naples 69
Redwood City 68
Boardman 62
Dong Ket 60
Turin 58
Boston 53
Napoli 48
Palermo 46
Catania 39
Bologna 38
Florence 35
Verona 34
Guangzhou 31
Bari 30
Jakarta 30
Padova 30
Hangzhou 28
New York 28
Mumbai 27
Toronto 27
Dallas 26
Genova 26
Fremont 24
Brussels 23
Nanjing 23
Tel Aviv 23
Des Moines 22
Mountain View 22
Shanghai 22
Düsseldorf 19
Hefei 19
Brescia 18
Parma 18
Seongnam 18
Menlo Park 17
Lappeenranta 16
Erlangen 15
Monza 15
Norwalk 15
Ottawa 15
Duncan 14
Genoa 14
Helsinki 14
Washington 14
Pescara 13
Pune 13
Trieste 13
Los Angeles 12
Messina 12
Vicenza 12
Durham 11
Glendale 11
Missaglia 11
San Diego 11
Tokyo 11
Buffalo 10
Delhi 10
Falls Church 10
Frankfurt am Main 10
Fuzhou 10
Hong Kong 10
Kuala Lumpur 10
Kunming 10
Massa 10
Phoenix 10
Piemonte 10
Seoul 10
Trento 10
Bangkok 9
Brindisi 9
Cagliari 9
Cinisello Balsamo 9
Segrate 9
Totale 7.338
Salva come PNG Salva come JPEG
Nome #
Somministrazione intravescicale di Mitomicina C in ipertermia nei carcinomi vescicali superficiali a rischio intermedio 3.696
L'alcol etilico nei farmaci chemioterapici antiblastici iniettabili: valutazioni ed implicazioni pratiche 1.708
Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I–II study 385
Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients 343
Validation of a simple and economic HPLC-UV method for the simultaneous determination of vancomycin, meropenem, piperacillin and tazobactam in plasma samples 305
PEGylation of proteins and liposomes, a powerful and flexible strategy to improve the drug delivery 304
Pharmacokinetic study to optimize the intravesical administration of gemcitabine 292
Antibiotic adjustment in CRRT 257
Farmacocinetica del paclitaxel in associazione con acido valproico nella terapia del tumore anaplastico della tiroide 228
Adherence to oral chemotherapy: Evidence from a randomised clinical trial 221
Messa a punto del metodo di estrazione e determinazione analitica, tramite HPLC, dell'amfotericina B su campioni ematici 184
Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies 178
Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial 170
Chemical and microbiological stability, anticoagulant efficacy and toxicity of 35 and 90 mM trisodium citrate solutions stored in plastic syringes 165
Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody 164
Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems. 161
Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives. 155
Glargine insulin loaded lipid nanoparticles: Oral delivery of liquid and solid oral dosage forms 155
Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae 154
A Pharmacokinetics Study to Optimize Intravesical Administration of Gemcitabine 146
Vaccini, sieri, immunoglobuline e anticorpi monoclonali 131
Targeted Cancer Therapy: The Roles Played by Antibody-Drug and Antibody-Toxin Conjugates 124
Hyaluronic Acid Conjugates as Vectors for the Active Targeting of Drugs, Genes and Nanocomposites in Cancer Treatment 114
Alternate scheduling of Gemcitabine (GEM) - Oxaliplatin (OXA) association in metastatic (MTS) or locally advanced (LA) pancreatic adenocarcinoma: a clinical and pharmacokinetic (pk) evaluation 110
Farmacocinetica della Gemcitabina (GEM) e del suo trifosfato (dFdCTP) in infusione prolungata a basse dosi in monochemioterapia in pazienti affetti da tumori solidi 107
Fenil vinil solfuri e metil vinil solfuri, inibitori specifici della ossidosqualene ciclasi di Trypanosoma cruzi e di S. cerevisiae. 105
Effects of the Molecular Weight of Hyaluronic Acid in a Carbon Nanotube Drug Delivery Conjugate 102
PHARMACOKINETICS, PHARMACOLOGICAL STABILITY, SAFETY AND ACTIVITY OF MMC ADMINISTERED WITH A NEW HYPERTHERMIA DEVICE (UNITHERMIA) 101
I medicinali senza obbligo di prescrizione in Pediatria. Tra raccomandazioni e automedicazione 101
A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al. 100
A pharmacokinetics study to optimize intravesical administration of gemcitabine 97
Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases 95
Farmacocinetica dell’associazione di vinorelbina orale con doxorubicina liposomiale peghilata nel tumore mammario metastatico 93
29-methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase. 90
Anti-TNF-α drugs: pharmacoeconomic analysis and proper use in pharmacological treatment in rheumatoid arthritis 88
19-azasqualene-2,3-epoxide and its N-oxide: metabolic fate and inhibitory effect on sterol biosynthesis in Saccharomyces cerevisiae 87
Pharmacokinetics, Pharmacological Stability, Safety and Efficacy of MMC Administered with a New Hyperthermia Device 86
Vinyl sulfide derivatives of oxidosqualene, as inhibitors of oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae. 82
Design of specific tools to evaluate the Cost Of Illness (COI) of Rheumatoid Arthritis 82
Farmacocinetica della somministrazione alternata della Gemcitabina (GEM) e Oxaliplatino (OXA) nei tumori pancreatici e delle vie biliari 81
Association of Gemcitabine (GEM) and Oxaliplatin (OXA) in metastatic or locally advanced pancreatic adenocarcinoma: a clinical and pharmacokinetic (PK) study 81
Coagulation Factor VIII: pharmacoeconomic evaluation and quality of life as measuring tools in clinical practice 81
An independent study about over the counter medicines to analyse parents’ awareness for paediatric use 81
Yeast Oxidosqualene cyclase (Erg7p) Is a Major Component of Lipid Particles. J. Biol. Chem. (2002) 277, 2406-2412. 80
Yeast Oxidosqualene cyclase (Erg7p) Is a Major Component of Lipid Particles 78
Administration of reduced glutathione in FOLFOX4 regimen in advanced colorectal cancer: effect on oxaliplatin pharmacokinetics and on Pt-DNA adducts formation 78
Paclitaxel e doxorubicina liposomiale peghilata in tumori testa/collo recidivanti: un’inaspettata interazione farmacocinetica intervallo-dipendente relativa alla somministrazione 78
Studio Farmacocinetico per determinare la modalità di somministrazione più idonea per la gemcitabina endovescicale 78
3-carboxy-4-nitrophenyl-dithio-1,1'-2-trisnorsqualene: a site directed inactivator of yeast oxidosqualene cyclase 77
Economic evaluation of different modalities of immunoglobulin therapy in chronic dysimmune polyradiculoneuropathies 77
2,3-oxidosqualene cyclase from yeast: a target enzyme for drug discovery. 74
Synthesis and biological activity of aryldithio and maleimido squalene derivatives as new irreversible inhibitors of squalene 2,3-oxide-lanosterol cyclase. 74
PHARMACOKINETICS, PHARMACOLOGICAL STABILITY AND SAFETY OF MMC ADMINISTERED WITH A NEW HYPERTHERMIA DEVICE 74
Subcellular localization of yeast oxidosqualene cyclase and other eukaryotic oxidosqualene cyclases expressed in yeast 73
Subcutaneous vs. intravenous immunoglobulin in CIDP: pharmacokinetic and clinical response 73
polyclonal antibodies against a fragment of oxidosqualene cyclase(erg7p) overexpressed in E.coli recognize the enzyme of different sources 71
The 3-keto reductase protein (Erg27p) is required for oxidosqualene cyclase (Erg7p) activity in yeast 71
Herbal Medicines in Children: between advice-giving and self-medication 71
Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity. 71
Thiol-modifying Inhibitors for Understanding Squalene Cyclase Function. Eur. J. Biochem. (2002) 269, 2108-2116. 70
Thiol-modifying agents as tools for understanding the function of squalene cyclase 70
Systematic analysis of yeast strains with possible defects in lipid metabolism 69
Studio farmacocinetico del Paclitaxel in associazione con acido valproico nella terapia del tumore anaplastico della tiroide 69
Comparison of the mechanism of yeast oxidosqualene cyclase and bacterial squalene cyclase by using rationally designed inhibitors. 68
Inhibition of sterol biosynthesis in Saccharomyces cerevisiae and Candida albicans by 22,23-epoxy-2-aza-2,3-dihydrosqualene and the corresponding N-oxide. 68
Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA: cholesterol O-acyltransferase inhibitors 67
Evidence of the existence of an essential thiol group within the active site of oxidosqualene cyclase from Saccharomyces cerevisiae 66
Comparative properties of N-ethoxycarbonyl-D-phenylalanyl-L-prolyl-alpha-azalysine p-nitrophenyl ester and N-ethoxycarbonyl-D-phenylalanyl-alpha-azaprolyl-L-lysine p-nitrophenyl ester as subsrates of serine proteinases 66
Preparation and characterization of novel PEG-paclitaxel derivatives 66
Nanotechnology Addressing Cutaneous Melanoma: The Italian Landscape 66
Active site titration of bovine beta-trypsin by N alpha-(N,N-dimethylcarbamoyl)-alpha-aza-lysine p-nitrophenyl ester: kinetic and crystallographic analysis 65
Yeast oxidosqualene cyclase (Erg7p) is a major component of lipid particles 64
Stereospecific inhibition of sterol biosynthesis in HEP G2 and Saccharomyces cerevisiae cell cultures by 29-methylidene-oxidosqualene derivatives. 63
Ottimizzazione della somministrazione endovescicale di gemcitabina: uno studio farmacocinetico 63
Subcellular localization of oxidosqualene cyclases from Arabidopsis thaliana, Trypanosoma cruzi and Pneumocystis carinii expressed in yeast 63
Self-Assembled Squalene-based Fluorescent Heteronanoparticles 63
Effect of proteases on microsomal oxidosqualene cyclases from Saccharomyces cerevisiae and Candida albicans 62
Conjugated Methyl Sulfide and phenyl Sulfide Derivatives of Oxidosqualene as Inhibitors of Oxidosqualene and Squalene-Hopene Cyclases. 60
Sterospecific irreversible inhibitors of liver and yeast oxidosqualene cyclase 60
The effect of five different administration intervals on the pharmacokinetics (pk) of paclitaxel (PTX) and pegylated liposomal doxorubicin (PLD) association regimen 60
Studio farmacocinetico e tossicologico dell’effetto neuroprotettivo del glutatione ridotto sulla chemioterapia basata sull’oxaliplatino nel carcinoma colon-rettale avanzato 59
Stereospecific synthesis of trans-vinyl dioxidosqualene and b-hydrosulfide derivatives, as potent and time-dependent 2,3-oxidosqualene cyclase inhibitors 58
In vitro metabolic fate of D2-thiazoline ring: evidence for the formation of a reactive metabolite in enzymatic-dependent D2-thiazoline ring cleavage 58
Study of sequence-dependent pharmacokinetic interactions between oral vinorelbine (VNR) and pegylated liposomal doxorubicin (PLD) in metastatic ovarian carcinoma 58
Clinical Assessment of Continuous Hemodialysis with the Medium Cutoff EMiC ® 2 Membrane in Patients with Septic Shock 58
Studio farmacocinetico dell’associazione di vinorelbina (VNR) per via orale con doxorubicina liposomale peghilata (PLD) nel carcinoma mammario metastatico 57
Synthesis and biological activity of new iodoacetamide derivatives on mutants of squalene-hopene cyclase 57
Effects of reduced glutathione (GSH) on oxaliplatin (OXA) in advanced colorectal cancer treated by FOLFOX4 regimen: Pharmacokinetics (PK) and determination of PtDNA adducts 56
Human alpha-thrombin inhibition by the highly selective compounds N-ethoxycarbonyl-D-Phe-Pro-alpha-azaLys p-nitrophenyl ester and N-carbobenzoxy-Pro-alpha-azaLys p-nitrophenyl ester: a kinetic, thermodynamic and X-ray crystallographic study 56
The impact of five different administration intervals on the pharmacokinetics (PK) of paclitaxel (PTX) and pegylated liposomal doxorubicin (PLD) combination 55
Synthesis and in vitro evaluation of new 4,5-diphenylthiazole derivatives as acyl-CoA:cholesterol O-acyl transferase inhibitors 55
Squalene- and nonsqualene-like thiol modifying agents as tools for understanding the function of squalene-hopene cyclase 55
Topology of DNA: when manipulation supports the lack of “space-filling” imagination 55
Macromolecules in Drug Delivery 51
Nanotechnological approaches for pentamidine delivery 51
Subcellular distribution and selective inhibition of oxidosqualene cyclases of Trypanosoma cruzi and Pneumocystis carinii expressed in Saccharomyces cerevisiae 50
Medicinali biologici ad alto costo e ad alta spesa nell'artrite reumatoide: tra sostenibilità ed opportunità 50
Paclitaxel and pegylated liposomal doxorubicin in recurrent head and neck cancer: Clinical and unexpected pharmacokinetic interactions 49
Paclitaxel and pegylated liposomal doxorubicin in recurrent head/neck cancer: clinical and pharmacokinetic preliminary data 49
Radiofarmaci 49
Totale 15.242
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.206
article - articoli 0
book - libri 0
conference - conferenze 18.503
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.709
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020973 0 0 0 0 0 0 211 124 154 150 172 162
2020/20212.365 255 139 154 179 270 155 203 127 260 218 172 233
2021/20221.828 95 97 91 115 137 109 117 136 62 101 376 392
2022/20232.647 273 162 124 260 247 556 256 161 248 103 156 101
2023/20241.447 136 214 117 95 83 138 62 82 21 153 138 208
2024/20251.529 91 143 131 301 687 132 44 0 0 0 0 0
Totale 16.823